Gregory A. Maynard, M.D., M.S., M.H.M. for UC Davis Health

Gregory A. Maynard, M.D., M.S., M.H.M.

Chief Quality Officer

Gregory A. Maynard is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).




Locations and Contact

2315 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Philosophy of Care

I strive to provide compassionate and professional care in the inpatient setting, along with other members of the healthcare team, partnering with the patient and their family.

Clinical Interests

Dr. Maynard's clinical interests are in quality improvement and safety of healthcare systems.

Research/Academic Interests

Dr. Maynard's research interests parallel his clinical and operational improvement interests; improving the quality, safety, and efficiency of patient care with research like rigor and innovative methods. He has extensive experience and publications focused on DVT prevention, inpatient glycemic control, prevention of adverse drug events, and transitions of care.



Undergraduate School

B.S., Western Illinois University, Macomb IL 1979

Medical School

M.D., University of Illinois College of Medicine, Peoria IL 1983

Other School

M.S., Biostatistics and Clinical Research Design, University of Michigan, Ann Arbor MI 1993


Internal Medicine, Good Samaritan Regional Medical Center/Carl Hayden VA, Phoenix AZ 1983-1984


Internal Medicine, Good Samaritan Regional Medical Center/Carl Hayden VA, Phoenix AZ 1984-1986


Chief Resident-Internal Medicine, Good Samaritan Regional Medical Center/Carl Hayden VA, Phoenix AZ 1986-1987

Healthcare-Associated VTE Prevention Challenge Champion, CDC, 2016

Master in Hospital Medicine, Society of Hospital Medicine (SHM), 2016

2011 John M. Eisenberg Patient Safety and Quality Award for SHM, from TJC / CMS, 2012

Venous Research Award for Implementation of Best Practices, Venous Disease Coalition, 2009

National Team Improvement Award, Society of Hospital Medicine, 2008

ACP Hospitalist Top Hospitalist Award, American College of Physicians, 2008

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Lu W, Spiro TE, Barnathan ES, Raskob GE. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol. 2020 Jun 30;75(25):3140-3147. doi:10.1016/j.jacc.2020.04.071. PMID:32586587.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi:10.1056/NEJMoa1805090. Epub 2018 Aug 26. PMID:30145946.

Jenkins IH, White RH, Amin AN, Afsarmanesh N, Auerbach AD, Khanna R, Maynard GA. Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers. J Hosp Med. 2016 Dec;11 Suppl 2:S22-S28. doi:10.1002/jhm.2658. PMID:27925421.

Maynard G. Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement, 2nd ed., Agency for Healthcare Research and Quality, Rockville, MD. 2015 Oct. AHRQ Publication No. 16-001-EF. 

Maynard G, Kulasa K, Ramos P, Childers D, Clay B, Sebasky M, Fink E, Field A, Renvall M, Juang PS, Choe C, Pearson D, Serences B, Lohnes S. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract. 2015 Apr;21(4):355-67. doi:10.4158/EP14367.OR. Epub 2014 Dec 22. PMID:25536971.

Li J, Hinami K, Hansen LO, Maynard G, Budnitz T, Williams MV. The physician mentored implementation model: a promising quality improvement framework for health care change. Acad Med. 2015 Mar;90(3):303-10. doi:10.1097/ACM.0000000000000547. PMID:25354069.

Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, Rogers K. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. J Diabetes Sci Technol. 2014 Jul;8(4):630-40. doi:10.1177/1932296814532237. Epub 2014 May 12. PMID:24876426.

Hofflich HL, Oh DK, Choe CH, Clay B, Tibble C, Kulasa KM, Shah PK, Fink E, Girard PJ, Schwartz AK, Maynard GA. Using a triggered endocrinology service consultation to improve the evaluation, management, and follow-up of osteoporosis in hip-fracture patients. Jt Comm J Qual Patient Saf. 2014 May;40(5):228-34. doi:10.1016/s1553-7250(14)40030-8. PMID:24919254.

Khanna R, Maynard G, Sadeghi B, Hensley L, Medvedev S, Danielsen B, White RH. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers. J Hosp Med. 2014 Apr;9(4):221-5. doi:10.1002/jhm.2159. Epub 2014 Feb 5. PMID:24497463.

Maynard G, Humber D, Jenkins I. Multidisciplinary initiative to improve inpatient anticoagulation and management of venous thromboembolism. Am J Health Syst Pharm. 2014 Feb 15;71(4):305-10. doi:10.2146/ajhp130108. PMID:24481155.